Učitavanje...
ASCO 2018 highlights: metastatic breast cancer
This article reviews the clinically most relevant presentations at the American Society of Clinical Oncology (ASCO) annual meeting 2018 on the topic of metastatic breast cancer. In the randomized placebo-controlled phase 3 trial MONALEESA-3, testing ribociclib vs. placebo in combination with fulvest...
Spremljeno u:
| Izdano u: | Memo |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Vienna
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280779/ https://ncbi.nlm.nih.gov/pubmed/30595753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-018-0450-9 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|